William Heard - 05 Aug 2025 Form 4 Insider Report for Anterix Inc. (ATEX)

Role
Director
Signature
/s/ Willliam E. Heard
Issuer symbol
ATEX
Transactions as of
05 Aug 2025
Net transactions value
$0
Form type
4
Filing time
07 Aug 2025, 17:49:41 UTC
Previous filing
04 Mar 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Heard William Director C/O HEARD CAPITAL LLC, 1 N. WACKER DRIVE, SUITE 3650, CHICAGO /s/ Willliam E. Heard 07 Aug 2025 0002035875

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ATEX Common Stock, par value $0.0001 per share ("Common Stock") Award $0 +7,767 +412% $0.000000 9,654 05 Aug 2025 Direct F1
holding ATEX Common Stock 1,716,738 05 Aug 2025 By Heard Capital LLC F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock granted to Mr. Heard as compensation of his service as a non-employee director on the Issuer's board of directors. The restricted stock vests in full on the earlier of (i) August 5, 2026 or (ii) the Issuer's next annual stockholder meeting; provided, however, that if the vesting would otherwise occur on a date that is closed for trading under the Issuer's Insider Trading Policy, the vesting shall be automatically deemed to occur on the next trading day on which the sale of shares of common stock by the Reporting Person in the open market would be permitted under the Issuer's Insider Trading Policy.
F2 These securities are held by certain investment funds and/or accounts for which Heard Capital LLC serves as investment manager. The Reporting Person is the ultimate beneficial owner of Heard Capital LLC. Each of Heard Capital LLC and the Reporting Person disclaims beneficial ownership of the securities to which this filing relates for purposes of Section 16 of the Securities and Exchange Act of 1934, as amended, except to the extent of his or its pecuniary interest therein.